PoRV causes a听disease听commonly referred to as 鈥渂lue eye disease鈥� because of the corneal opacity seen in some affected pigs
The global market for Blue Eye Disease Vaccines was estimated to be worth US$ 157.5 million in 2023 and is forecast to a readjusted size of US$ 212.8 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030
The increasing prevalence of Blue Eye Disease, a viral infection affecting livestock, is driving the demand for vaccines. Factors such as rising awareness about animal health, government initiatives for disease control, and the growing livestock industry contribute to market expansion. Key players in the market are investing in research and development to develop effective and affordable vaccines. Additionally, advancements in biotechnology and vaccine manufacturing processes are expected to propel market growth. However, challenges such as stringent regulations and limited awareness in certain regions may hinder market growth. Overall, the Blue Eye Disease vaccines market is anticipated to witness substantial growth in the foreseeable future.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blue Eye Disease Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Blue Eye Disease Vaccines by region & country, by Type, and by Application.
The Blue Eye Disease Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blue Eye Disease Vaccines.
麻豆原创 Segmentation
By Company
CAHIC
Boehringer Ingelheim
MSD Animal Health
Chopper Biology
Ceva
Ringpu Biology
Qilu Animal
DHN
Segment by Type:
Live Vaccines
Killed Vaccines
Segment by Application
Piglets
Adult Pigs
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blue Eye Disease Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Blue Eye Disease Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Blue Eye Disease Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Blue Eye Disease Vaccines Product Introduction
1.2 Global Blue Eye Disease Vaccines 麻豆原创 Size Forecast
1.2.1 Global Blue Eye Disease Vaccines Sales Value (2019-2030)
1.2.2 Global Blue Eye Disease Vaccines Sales Volume (2019-2030)
1.2.3 Global Blue Eye Disease Vaccines Sales Price (2019-2030)
1.3 Blue Eye Disease Vaccines 麻豆原创 Trends & Drivers
1.3.1 Blue Eye Disease Vaccines Industry Trends
1.3.2 Blue Eye Disease Vaccines 麻豆原创 Drivers & Opportunity
1.3.3 Blue Eye Disease Vaccines 麻豆原创 Challenges
1.3.4 Blue Eye Disease Vaccines 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Blue Eye Disease Vaccines Players Revenue Ranking (2023)
2.2 Global Blue Eye Disease Vaccines Revenue by Company (2019-2024)
2.3 Global Blue Eye Disease Vaccines Players Sales Volume Ranking (2023)
2.4 Global Blue Eye Disease Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Blue Eye Disease Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Blue Eye Disease Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Blue Eye Disease Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Blue Eye Disease Vaccines
2.9 Blue Eye Disease Vaccines 麻豆原创 Competitive Analysis
2.9.1 Blue Eye Disease Vaccines 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Blue Eye Disease Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blue Eye Disease Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Live Vaccines
3.1.2 Killed Vaccines
3.2 Global Blue Eye Disease Vaccines Sales Value by Type
3.2.1 Global Blue Eye Disease Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Blue Eye Disease Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Blue Eye Disease Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Blue Eye Disease Vaccines Sales Volume by Type
3.3.1 Global Blue Eye Disease Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Blue Eye Disease Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Blue Eye Disease Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Blue Eye Disease Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Piglets
4.1.2 Adult Pigs
4.2 Global Blue Eye Disease Vaccines Sales Value by Application
4.2.1 Global Blue Eye Disease Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Blue Eye Disease Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Blue Eye Disease Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Blue Eye Disease Vaccines Sales Volume by Application
4.3.1 Global Blue Eye Disease Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Blue Eye Disease Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Blue Eye Disease Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Blue Eye Disease Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Blue Eye Disease Vaccines Sales Value by Region
5.1.1 Global Blue Eye Disease Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Blue Eye Disease Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Blue Eye Disease Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Blue Eye Disease Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Blue Eye Disease Vaccines Sales Volume by Region
5.2.1 Global Blue Eye Disease Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Blue Eye Disease Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Blue Eye Disease Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Blue Eye Disease Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Blue Eye Disease Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Blue Eye Disease Vaccines Sales Value, 2019-2030
5.4.2 North America Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Blue Eye Disease Vaccines Sales Value, 2019-2030
5.5.2 Europe Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Blue Eye Disease Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Blue Eye Disease Vaccines Sales Value, 2019-2030
5.7.2 South America Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Blue Eye Disease Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Blue Eye Disease Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Blue Eye Disease Vaccines Sales Value
6.2.1 Key Countries/Regions Blue Eye Disease Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Blue Eye Disease Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Blue Eye Disease Vaccines Sales Value, 2019-2030
6.3.2 United States Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Blue Eye Disease Vaccines Sales Value, 2019-2030
6.4.2 Europe Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Blue Eye Disease Vaccines Sales Value, 2019-2030
6.5.2 China Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Blue Eye Disease Vaccines Sales Value, 2019-2030
6.6.2 Japan Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Blue Eye Disease Vaccines Sales Value, 2019-2030
6.7.2 South Korea Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Blue Eye Disease Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Blue Eye Disease Vaccines Sales Value, 2019-2030
6.9.2 India Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 CAHIC
7.1.1 CAHIC Company Information
7.1.2 CAHIC Introduction and Business Overview
7.1.3 CAHIC Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 CAHIC Blue Eye Disease Vaccines Product Offerings
7.1.5 CAHIC Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Information
7.2.2 Boehringer Ingelheim Introduction and Business Overview
7.2.3 Boehringer Ingelheim Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Blue Eye Disease Vaccines Product Offerings
7.2.5 Boehringer Ingelheim Recent Development
7.3 MSD Animal Health
7.3.1 MSD Animal Health Company Information
7.3.2 MSD Animal Health Introduction and Business Overview
7.3.3 MSD Animal Health Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 MSD Animal Health Blue Eye Disease Vaccines Product Offerings
7.3.5 MSD Animal Health Recent Development
7.4 Chopper Biology
7.4.1 Chopper Biology Company Information
7.4.2 Chopper Biology Introduction and Business Overview
7.4.3 Chopper Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Chopper Biology Blue Eye Disease Vaccines Product Offerings
7.4.5 Chopper Biology Recent Development
7.5 Ceva
7.5.1 Ceva Company Information
7.5.2 Ceva Introduction and Business Overview
7.5.3 Ceva Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ceva Blue Eye Disease Vaccines Product Offerings
7.5.5 Ceva Recent Development
7.6 Ringpu Biology
7.6.1 Ringpu Biology Company Information
7.6.2 Ringpu Biology Introduction and Business Overview
7.6.3 Ringpu Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Ringpu Biology Blue Eye Disease Vaccines Product Offerings
7.6.5 Ringpu Biology Recent Development
7.7 Qilu Animal
7.7.1 Qilu Animal Company Information
7.7.2 Qilu Animal Introduction and Business Overview
7.7.3 Qilu Animal Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Qilu Animal Blue Eye Disease Vaccines Product Offerings
7.7.5 Qilu Animal Recent Development
7.8 DHN
7.8.1 DHN Company Information
7.8.2 DHN Introduction and Business Overview
7.8.3 DHN Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 DHN Blue Eye Disease Vaccines Product Offerings
7.8.5 DHN Recent Development
8 Industry Chain Analysis
8.1 Blue Eye Disease Vaccines Industrial Chain
8.2 Blue Eye Disease Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Blue Eye Disease Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Blue Eye Disease Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
CAHIC
Boehringer Ingelheim
MSD Animal Health
Chopper Biology
Ceva
Ringpu Biology
Qilu Animal
DHN
听
听
*If Applicable.